Teva Pharmaceutical Industries ($TEVA) Insider Trading & Smart Money Activity
Teva Pharmaceutical Industries Limited ($TEVA) has 4 insider trades, 1 congress trade, 1 13F position change and 4 analyst ratings on file. In the last 12 months on the open market, no insider bought and 4 insiders sold ($18.60M), net -$18.60M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 4
- Net insider $ (12 mo)
- -$18.60M
- Congress trades (12 mo)
- 1
- 13F moves on file
- 1
- Analyst ratings on file
- 4
TEVA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 1 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $3.96M | 0 / 0 | 1 / 0 |
| Q3 2026 | 0 | 2 · $14.64M | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All TEVA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | Barclays | Reiterates to Overweight | PT $47 | Read | |||||||
| Analyst | JP Morgan | Reiterates to Overweight | PT $50 | Read | |||||||
| Analyst | TD Cowen | Reiterates to Buy | PT $55 | -0.2% | — | ||||||
| Analyst | Oppenheimer | Reiterates to Outperform | PT $50 | +1.5% | — | ||||||
| Insider | Savage BrianInterim Chief Legal Officer | Sell (Open-market sale) | 7.34K sh | $285.22K | +0.5% | — | |||||
| Insider | Roberto MignoneDirector | Sell (Open-market sale) | 367.60K sh | $14.36M | +0.5% | — | |||||
| Insider | Matthew ShieldsEVP, Global Operations | Sell (Open-market sale) | 9.99K sh | $321.55K | +6.8% | -1.5% | Read | ||||
| Insider | Kalif Eliyahu SharonEVP, Chief Financial Officer | Sell (Open-market sale) 10b5-1 | 106.56K sh | $3.63M | -8.9% | -6.9% | Read | ||||
| 13F | Wcm Investment Management | Added | +26.81M sh | $1.38B | -1.9% | -7.6% | — | ||||
| Congress | Alan Armstrong | Purchase | $1,001 - $15,000 | +5.2% | +24.8% | +37.1% | — |
1W / 1M / 6M = how TEVA moved from the trade or filing date.
Insider trading in TEVA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Savage Brian | Interim Chief Legal Officer | 1 | -$285.22K | Sep 18, 2026 | |
| Roberto Mignone | Director | 1 | -$14.36M | Sep 18, 2026 | |
| Matthew Shields | EVP, Global Operations | 1 | -$321.55K | Jun 18, 2026 | |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | 1 | -$3.63M | Jun 11, 2026 |
Members of Congress trading TEVA
Institutions moving TEVA (13F)
Analyst ratings on TEVA
Frequently asked questions
Are TEVA insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 4 insiders made 4 open-market sales worth $18.60M, a net -$18.60M.
What is the latest insider trade in TEVA?
Savage Brian, Interim Chief Legal Officer filed a sell (open-market sale) of 7.34K sh worth $285.22K on Sep 18, 2026.
Which members of Congress traded TEVA?
1 disclosed trade by Alan Armstrong. The latest was on Mar 30, 2026.
Which institutions changed their TEVA positions?
Recent 13F filers moving the stock include Wcm Investment Management.
Other drug manufacturers - specialty & generic stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.